Literature DB >> 7912510

H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.

J A Anderson1, J C Irish, C M McLachlin, B Y Ngan.   

Abstract

OBJECTIVE: Previous in vitro studies have demonstrated that transfection of an activated ras gene induces malignant transformation in epithelial cell lines infected with the human papillomavirus (HPV). The results of these studies support the hypothesis that HPV may cooperate with an activated ras gene in epithelial tumor carcinogenesis. To test this hypothesis in head and neck cancers, we screened 35 oral carcinomas for the presence of HPV DNA and for a mutated H-ras gene.
DESIGN: The design of the study was screening survey type. Twenty-seven oral squamous cell carcinomas and eight verrucous carcinomas were analyzed for the presence of HPV DNA using the polymerase chain reaction, followed by Southern blot and probe hybridization. The tumors were also screened for point mutations of the H-ras gene using the polymerase chain reaction and restriction fragment length polymorphism analysis.
RESULTS: Six (22%) of the 27 oral squamous cell carcinomas demonstrated point mutation in the H-ras gene. In addition, six tumors (22%) were positive for HPV DNA, with three tumors (11%) demonstrating both HPV DNA and H-ras gene point mutation. While the rate of simultaneous HPV infection and ras gene activation by point mutation was 11% in oral squamous cell carcinomas, 25% of oral verrucous carcinomas contained both HPV DNA and mutation in the H-ras gene.
CONCLUSIONS: These results suggest a stronger association between HPV infection and activation of the H-ras gene in oral verrucous carcinomas. These results continue to confirm the multihit hypothesis of tumorigenesis and suggest that in some cases of oral cancer at least two of these events are H-ras gene mutation and HPV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912510     DOI: 10.1001/archotol.1994.01880310059011

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  19 in total

Review 1.  Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.

Authors:  Vijayvel Jayaprakash; Mary Reid; Elizabeth Hatton; Mihai Merzianu; Nestor Rigual; James Marshall; Steve Gill; Jennifer Frustino; Gregory Wilding; Thom Loree; Saurin Popat; Maureen Sullivan
Journal:  Oral Oncol       Date:  2011-08-03       Impact factor: 5.337

2.  HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.

Authors:  J Hun Hah; Mei Zhao; Curtis R Pickering; Mitchell J Frederick; Genevieve A Andrews; Samar A Jasser; David R Fooshee; Zvonimir L Milas; Chad Galer; Daisuke Sano; William N William; Edward Kim; John Heymach; Lauren A Byers; Vali Papadimitrakopoulou; Jeffrey N Myers
Journal:  Head Neck       Date:  2014-03-20       Impact factor: 3.147

3.  Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.

Authors:  Rodney B Luwor; Yang Lu; Xinqun Li; Ke Liang; Zhen Fan
Journal:  Cancer Lett       Date:  2011-03-15       Impact factor: 8.679

4.  Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

Authors:  Karl C Bruckman; Frank Schönleben; Wanglong Qiu; Victoria L Woo; Gloria H Su
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-09-01

Review 5.  Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Roland L Dunbrack; Matthew K Robinson; Barbara Burtness; Erica A Golemis
Journal:  Drug Resist Updat       Date:  2011-09-14       Impact factor: 18.500

Review 6.  Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

Authors:  Carolien Boeckx; Marc Baay; An Wouters; Pol Specenier; Jan B Vermorken; Marc Peeters; Filip Lardon
Journal:  Oncologist       Date:  2013-07-02

Review 7.  The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.

Authors:  Katinka Kansy; Oliver Thiele; Kolja Freier
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

8.  Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer.

Authors:  Jamboor K Vishwanatha; Ryan Swinney; Abhijit G Banerjee
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

Review 9.  The molecular pathogenesis of head and neck squamous cell carcinoma.

Authors:  S Michael Rothenberg; Leif W Ellisen
Journal:  J Clin Invest       Date:  2012-06       Impact factor: 14.808

10.  Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.

Authors:  Ann Marie Egloff; Jennifer Rubin Grandis
Journal:  J Oncol       Date:  2009-07-14       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.